Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Call for Papers: New Thematic Series

                             © Rost-9D / Getty Images / iStock

For the third consecutive year, Molecular Cancer is excited to announce a new thematic series covering the general research area of Non-coding RNAs and RNA modifiers in cancer progression and cancer cells resistance to therapies. Of particular focus are original research papers reporting data from clinical trials or animal models. In addition to original research articles, we aim to publish letters to the Editor and comprehensive reviews.

All submitted manuscripts will undergo rigorous initial evaluation within 7 days, and then, when appropriate, will be sent out for external peer review to assess the suitability for publication. Submit here.

Submission deadline: December 15th, 2019

Expected publication date: February 2020

Thematic Series Published in 2019: Microvesicles and Tumor Microenvironment in Cancer Development and Resistance to Therapies

This series of review articles aims to highlight significant findings and advances in our understanding of the role of the TME in cancer biology. The tumor microenvironment (TME) has an effect on tumor development, growth, and resistance to therapy. Continuous interactions and exchanges between tumor cells and the TME are involved in angiogenesis, tumor genetic diversity, immune escape, and metastasis.

Featured Article: Role of the NLRP3 inflammasome in cancer

​​​​​​​In this review, Sahebkar et al. summarize the current knowledge on the contribution of the NLRP3 inflammasome on potential cancer promotion and therapy.

Thematic Series Published in 2018

Series of Review Articles: Oncogenic Signaling of Tyrosine Kinase in Cancer: Challenges and Therapeutic Opportunities



Christophe Nicot, Kansas University Medical Center, USA

Aims and scope

Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.

Read more


Annual Journal Metrics